Overview
- 32 inspections across 32 sites are on record.
- 83 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-07-01.
At a glance
Inspections
32
Sites
32
Observations
83
Career since
Apr 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Baxalta US Inc. | 1 Jul 2021 | Biologics | On file |
| Celgene Corporation | 19 Feb 2021 | Biologics | On file |
| Millipore (U.K.) Ltd. | 27 Feb 2020 | Biologics | View 483 → |
| CSL Behring AG | 18 Feb 2020 | Biologics | On file |
| Cleveland Cord Blood Center | 17 Jan 2020 | Biologics | View 483 → |
Sites inspected
Baxalta US Inc.Social Circle, United States1 insp.
Celgene CorporationSummit, United States1 insp.
Millipore (U.K.) Ltd.Livingston, United Kingdom1 insp.
CSL Behring AGBern, Switzerland1 insp.
Cleveland Cord Blood CenterWarrensville Heights, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Prabhu P Raju3 shared
Judy E Ciaraldi2 shared
William F Lagud2 shared
Massoud Motamed2 shared
Kimberly L Schultz1 shared
Janet L Bowen1 shared
Linda Thai1 shared
Yvesna C Blaise1 shared
Gene D Arcy1 shared
Matthew W Klinker1 shared
Full investigator report
Get the verbatim findings behind Nimmy Mathews' 83 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site